Save the Date for our Annual NAAF Patient Conference - Reaching New Summits Together - June 30 - July 2, 2023 in Denver, Colorado!
18 to 70 years of age; have patchy alopecia areata
This study is being done for research purposes to evaluate the safety and tolerability of applying a topical form of an investigational JAK inhibitor in adults with alopecia areata.
You may qualify to participate in this study if you:*
*There are additional requirements as determined by a screening process.–
If you qualify, you will need to come to the study center up to 7 times over a 4 month period. At these visits, the study doctor will closely monitor your alopecia areata and discuss your overall experiences with the study drug and your participation in the study.
This study is taking place at locations throughout the United States.
Please visit alopeciaareatastudy.com for more information.